| Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MWY Foo, ... Journal of the American Society of Nephrology 23 (6), 1097-1107, 2012 | 227 | 2012 |
| Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease P Ferrari, H Kulkarni, S Dheda, S Betti, C Harrison, TGS Pierre, JK Olynyk Clinical Journal of the American Society of Nephrology 6 (1), 77-83, 2011 | 154 | 2011 |
| Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure S Prakash, DP Pande, S Sharma, D Sharma, CS Bal, H Kulkarni Journal of renal nutrition 14 (2), 89-96, 2004 | 117 | 2004 |
| The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MWY Foo, ... Nephrology Dialysis Transplantation 27 (12), 4445-4453, 2012 | 115 | 2012 |
| The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: The Balanz Trial bal ANZ Trial Writing Committee: Peritoneal Dialysis International 32 (5), 497-506, 2012 | 79 | 2012 |
| High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population R Singer, HC RHODES, G Chin, H Kulkarni, P Ferrari Nephrology 13 (1), 17-22, 2008 | 58 | 2008 |
| Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial SD Roger, CA Gaillard, AH Bock, F Carrera, KU Eckardt, DB Van Wyck, ... Nephrology Dialysis Transplantation 32 (9), 1530-1539, 2017 | 44 | 2017 |
| Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin R Howman, H Kulkarni Nephrology Dialysis Transplantation 22 (5), 1462-1464, 2007 | 41 | 2007 |
| Successful treatment of renal allograft and bladder malakoplakia with minimization of immunosuppression and prolonged antibiotic therapy AL Graves, M Texler, L Manning, H Kulkarni Nephrology 19, 18-21, 2014 | 33 | 2014 |
| Escherichia coli ‘O’group serological responses and clinical correlations in epidemic HUS patients H Kulkarni, PN Goldwater, A Martin, KA Bettelheim Comparative immunology, microbiology and infectious diseases 25 (4), 249-268, 2002 | 32 | 2002 |
| Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis R Holman, JK Olynyk, H Kulkarni, P Ferrari Nephrology 22 (2), 114-117, 2017 | 29 | 2017 |
| balANZ Trial Investigators: The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: The balANZ … DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MW Foo, ... Nephrol Dial Transplant 27 (12), 4445-4453, 2012 | 17 | 2012 |
| Intra‐ureteric capsaicin in loin pain haematuria syndrome: efficacy and complications D Playford, H Kulkarni, M Thomas, J Vivian, A Low, J Mander, D Perlman, ... BJU international 90 (6), 518-521, 2002 | 17 | 2002 |
| Performance evaluation of full scale wastewater treatment facility for finished leather industry SN Kaul, PK Mukherjee, TA Sihorwala, H Kulkarni, T Nandy Journal of Environmental Science & Health Part A 28 (6), 1277-1286, 1993 | 12 | 1993 |
| Subjective and quantitative assessment of patient fitness for cadaveric kidney transplantation: the “equity penalty” MAB Thomas, G Luxton, HR Moody, AJ Woodroffe, H Kulkarni, W Lim, ... Transplantation 75 (7), 1026-1029, 2003 | 8 | 2003 |
| balANZ Trial Investigators: The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: The balANZ trial DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MW Foo, ... Perit Dial Int 32, 497-506, 2012 | 7 | 2012 |
| Causality of rhabdomyolysis and combined tetanus, diphtheria and acellular pertussis (Tdap) vaccine administration. H Kulkarni, N Lenzo, A McLean‐Tooke Journal of clinical pharmacology 53 (10), 2013 | 4 | 2013 |
| Development of an artificial intelligence model to predict survival at specific time intervals for lung cancer patients. S Agrawal, V Vaidya, P Chandrashekaraiah, H Kulkarni, L Chen, ... Journal of Clinical Oncology 37 (15_suppl), 6556-6556, 2019 | 2 | 2019 |
| A case of Legionella longbeachae pneumonia complicated by rhabdomyolysis and acute renal failure requiring hemodialysis BM Clark, P Boan, HA Kulkarni Infectious Diseases in Clinical Practice 18 (6), 413-416, 2010 | 2 | 2010 |
| Randomized double blind placebo controlled trial of ketoanalogues in retardation of chronic renal failure in tropics [abstract no: M416] S Prakash, D Pande, K Suresh, H Kulkarni Nephrology Dialysis Transplantation 18 (4), 130, 2003 | 2 | 2003 |
Paolo FerrariProfessor of Medicine, UNSW, Sydney and USI, LuganoVerified email at eoc.ch
